학술논문

Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin
Document Type
Article
Source
In: Clinical Colorectal Cancer. (Clinical Colorectal Cancer, December 2023, 22(4):450-456.e1)
Subject
Language
English
ISSN
19380674
15330028